Abstract

Transdermal drug delivery systems (TDDS) offer a promising avenue for efficient drug administration, bypassing the limitations of traditional routes. This review delves into the latest advancements and innovative approaches revolutionizing TDDS. Beginning with an exploration of the intricate anatomy and physiology of the skin and the mechanisms governing drug penetration, it provides a foundational understanding crucial for optimizing transdermal delivery. The review then scrutinizes the advantages and drawbacks inherent in TDDS, elucidating their potential for enhancing patient compliance and therapeutic efficacy while addressing challenges such as limited drug permeability and skin irritation. Moreover, it delineates various types of TDDS, ranging from passive to actively assisted methods, each tailored to accommodate diverse therapeutic needs. A focal point of this review is the examination of electrically driven or assisted methods, including iontophoresis, sonophoresis, electroporation, photomechanical waves, microneedle technologies, thermal ablation, vesicles, polymeric nanoparticles, and nanoemulsion-based systems. These cutting-edge techniques harness the power of electrical, mechanical, and thermal stimuli to facilitate precise drug delivery, augmenting permeation through the skin barrier and optimizing therapeutic outcomes. Furthermore, the review scrutinizes methodological advancements, such as diffusion cell techniques, tape stripping, and microscopic and spectroscopic methods, essential for evaluating drug-vehicle interactions and modulating the stratum corneum for enhanced permeability. It also underscores recent strides in modifying drug vehicles and skin barriers to overcome challenges in drug delivery, paving the way for tailored and efficient therapeutic interventions. In summary, this review encapsulates the dynamic landscape of advancements and innovative strategies shaping the future of transdermal drug delivery. By synthesizing current knowledge and highlighting emerging trends, it offers valuable insights for researchers, clinicians, and pharmaceutical developers striving to harness the full potential of TDDS for improved patient care and treatment outcomes.

Keywords

Enhancement methods · Microneedles · Innovative Approaches · Transdermal drug delivery

Introduction

Transdermal drug delivery structures (TDDS) are a form of medication delivery device that works by handing over capsules via an affected person's skin. Additionally called "patches," these structures are designed to provide a therapeutically powerful amount of the drug for systemic consequences. To attain this, the pores and skin's comprehensive morphological, biophysical, and physicochemical properties should be considered. Transdermal transport has several advantages over different drug delivery methods, which include injectables and oral routes. For example, it increases patient compliance by fending off the need for common dosing and reduces the hazard of first-skip metabolism. It also offers the drug in a managed and consistent way, which removes pulsed access into the systemic move and decreases the danger of aspect results. Due to the advantages of transdermal drug shipping, numerous types of novel drug delivery systems have emerged, which include transdermal drug shipping systems, controlled release systems, and transmucosal shipping structures. These systems have the potential to offer even more blessings to sufferers by way of enhancing drug efficacy and reducing aspect results. One of the giant blessings of transdermal drug shipping is the hassle of hepatic first-pass metabolism, which can lessen the quantity of drug that reaches the bloodstream. By bypassing this system, the drug can be added greater correctly, which may enhance its healing performance. Additionally, transdermal drug delivery can help preserve the regular plasma degrees of the drug, which can be especially beneficial for drugs with quick organic half of lives. The primary transdermal gadget changed into permitted by the FDA in 1979. Known as Transderm-SCOP, this system is designed to save you nausea and vomiting associated with a journey, specifically through the sea. In view that then, several transdermal drug transport systems had been advanced for numerous applications, inclusive of ache control, hormone substitute therapy, and smoking cessation. The proof of drug absorption via the skin may be located in various ways, which include measurable blood ranges of the drug, detectable excretion of the drug and its metabolites in the urine, and the medical reaction of the patient to the remedy. Those techniques can assist decide the effectiveness of the transdermal drug shipping device and determine whether or not it is the first-rate alternative for a specific affected person. In conclusion, transdermal drug shipping structures offer several blessings over other drug shipping techniques. They can improve patient compliance, reduce the risk of side consequences, and enhance drug efficacy. With the improvement of recent transdermal drug transport systems, patients can count on even greater blessings from this revolutionary drug delivery approach. Transdermal drug transport systems (TDDS) have become a more and more famous way to supply remedies to sufferers. These structures use a patch that is placed at the pores and skin and provides a remedy through the pores and skin and into the bloodstream.  The patch is made up of numerous elements, each of which serves a selected cause.  API: one of the key components in a TDDS is the drug itself. The drug is in direct contact with the release liner and is designed to be absorbed through the skin. Examples of medicine that may be brought through TDDS include nicotine, methotrexate, and estrogen.  Liner: This is designed to guard the patch in the course of storage and is generally crafted from materials like polyester film. This helps to make sure that the drug stays stable and effective till it is prepared for use.

Adhesive: it's almost every other critical element of a TDDS. This is what lets the patch paste to the skin and delivers the medication systemically. Adhesive substances utilized in TDDS consist of acrylates, polyisobutylene, and silicones.  Permeation enhancers: those are also used in TDDS to assist control the release of the drug. These substances can include terpenes, terpenoids, pyrrolidones, and solvents like alcohol, ethanol, and methanol.  Surfactants: substances like sodium lauryl sulfate, Pluronic F127, and Pluronic F68 also can be used.The backing layer is used to protect the patch from the surroundings. This accretion is normally made from materials like cellulose derivatives, polyvinyl alcohol, polypropylene, and silicon rubber. It facilitates making certain that the patch remains intact and strong throughout use. Usually, TDDS is a safe and effective manner to supply medication to sufferers. By expertise in the one-of-a-kind substances utilized in these systems, healthcare carriers can ensure that their sufferers get the medicine they need correctly and effectively.

Anatomy and Physiology of skin and Penetration of drug through skin:

Understanding the anatomy and physiology of skin is crucial when it comes to transdermal delivery of drugs. Skin is the largest organ in the human body, and it plays a vital role in protecting the body against harmful microbes and producing sensory responses. The skin is also responsible for administering drugs to the body, and its different layers are crucial for the delivery process. The skin is made up of three primary layers, each with a unique function. These layers are the epidermis (20-89 µm), dermis(0.3-3 mm), and hypodermis(1-2mm).  The epidermis is the outermost layer of the skin, which consists of a striated, vascular, and cellular structure. This layer is present in different regions of the body with varying thickness. It has two types of epidermal layers, the stratum corneum and the viable epidermis.  The stratum corneum is also known as the honey layer and is responsible for preventing the penetration of drugs into the body. It is the outermost layer of the skin and is made up of 10-25 layers of keratinized dead cells known as corneocytes. The lipid-soluble topical agents can penetrate this layer, but they act as a principal barrier to the penetration of drugs. The lipid molecules are aligned in multiple bilayers, which prevent excessive loss of water from the body.

 The viable epidermis is located beneath the stratum corneum and comprises several layers such as stratum granulosum, stratum lucidum, stratum spinosum, and stratum basal. This layer is responsible for the penetration of drugs through the skin.  The dermis is made up of connective tissues such as lymph, nerves, and blood vessels. It is responsible for providing oxygen to the skin and eliminating waste products and toxins. Sweat glands and hair follicles are present in this region.

The hypodermis is the deepest layer of the skin and comprises subcutaneous fat tissue. It supports the dermis and epidermis helps regulate body temperature, provides mechanical protection, and supports nutrients.  When it comes to the penetration of drugs through the skin, drug molecules penetrate directly to the stratum corneum through three pathways, hair follicles, sweat ducts, and sebaceous glands. The molecules migrate through the barrier, and this migration happens because of the external force applied to individual solute molecules.  The penetration of drugs through the outer membrane of the stratum corneum obeys Fick's first law. The law states that the flux is directly proportional to the concentration gradient. The flux is determined using an equation that takes into account the mass of the compound, the area of the cross-section, and the time. The molecular transport of drugs through the barrier is determined by fluxes, and it is crucial for the transdermal delivery of drugs.

J=m/At

where,

 J=Flux,

 m=Mass of compound,

 An area of cross-section,

 t=Time.

The molecules are migrating through the barrier; this migration happens because of external force applied to individual solute molecules [9]. Penetration of drugs through the outer membrane of the stratum corneum obeys Fick’s first law.

Fick’s first law states that flux is directly proportional to the concentration gradient. Fick’s first law determined using an equation.

dm/dt=?DS (dC/dx)

ADVANTAGES & DISADVANTAGES OF TDDS:

Advantages Of TDDS

• Reduce the peak plasma levels of the drug this leads to a decrease the side effect
• Reduce the fluctuation in plasma levels of drugs
• Avoid 1st pass metabolism of the drug It is a painless treatment
• Enhancement of patient compliance
• Reduction of dosing frequency
• Easy elimination of drugs in increased toxicity

Disadvantages Of TDDS

• Drugs having very low or high partition coefficients fail to reach the systemic circulation
• Patients having higher molecular weight fail to penetrate the stratum corneum
• High melting of the drug due to low solubility of both water and fat

Types of Transdermal Drug Delivery System:

Transdermal drug delivery systems (TDDS) are becoming increasingly popular due to their numerous benefits such as controlled drug release, fewer side effects, and improved patient compliance. TDDS can be classified into three types: reservoir system, matrix system, and micro reservoir system. (TDDS) are becoming increasingly popular due to their numerous benefits such as controlled drug release, fewer side effects, and improved patient compliance.

TDDS can be classified into three types: reservoir system, matrix system, and micro reservoir system.

reservoir system:

It is a type of TDDS where the drug reservoir is aligned between the backing layer and rate-controlling membrane. The drug may be in the form of suspension, gel, or solution, which is dispersed on the solid polymeric matrix. It is an effective way to deliver drugs that have a high permeability rate. Matrix System, on the other hand, is classified into two types of systems: drug adhesive system and matrix dispersion system. In the drug adhesive system, the drug reservoir is formed by the dispersion of the drug to an adhesive polymer. It is then spread on the medicated adhesive polymer or melted on the backing layer.

 In the matrix dispersion system, the drugs are homogeneously dispersed on the lipophilic or hydrophilic polymer matrix. The drugs having polymer are fitted on a particular base plate. From a drug impermeable backing layer, it self-spreads to form a strip of adhesive rim instead of applying the adhesive or phase of the drug reservoir.

Microreservoir System:

It is a combination of matrix and reservoir systems. In this system, the drug is first dissolved in an aqueous solution of a water-soluble polymer, and then it is dispersed in lipophilic polymers to form microscopic spheres of the drug reservoir. This system provides a sustained release of drugs over an extended period. In summary, TDDS has revolutionized drug delivery, providing a convenient and efficient way of administering drugs. The choice of TDDS depends on the type of drug, its properties, and the desired therapeutic effect.

ADVANCEMENTS IN  TRANSDERMAL DRUG DELIVERY SYSTEM(TDDS):

External stimuli can improve skin permeability of drugs and biomolecules, compared to topical application. This enhanced transdermal drug delivery system (TDDS) is known as active transdermal delivery, which delivers drugs faster and more reliably. This method can also accelerate the therapeutic efficacy of delivered drugs and these stimulis can be mechanical , electrical, or physical which increases the permeability of drug to layers of skin .

Electrically Driven/Assisted Methods :

Transdermal delivery refers to the administration of drugs through the skin. Electrically assisted methods have been developed to enhance the absorption of drugs into the skin. These methods use electrical devices to deliver energy to the skin. According to Prausnitz and Langer's classification and Morrow et al., these energy-driven methods can be divided into two generations.The second generation of electrically assisted methods includes iontophoresis and noncavitational ultrasound. However, the impact of iontophoresis on the stratum corneum (SC) is limited since it does not create microchannels or remove the SC, unlike the third generation methods of electroporation, sonophoresis, and thermal ablation. Prausnitz and Langer classify iontophoresis as the second generation since it has limited impact on the SC. The third generation of methods creates microchannels or removes the SC, which improves drug absorption through the skin. Overall, electrically assisted methods have shown great potential in enhancing transdermal drug delivery, and further research could lead to their widespread use in the medical field.

Iontophoresis

Iontophoresis is a technique that uses a small externally applied potential difference(less than 0.5 mA/cm2) to promote the movement of ions across the membrane. This enhances skin penetration and increases the release rate of drugs that are difficult to absorb. The efficacy of iontophoresis depends on the drug molecule's polarity, valency, mobility, and the applied electrical cycle. It is less dependent on biological parameters and can include electronic reminders for patients to change dosages to increase compliance.

Sonophoresis

Transdermal drug delivery is a promising approach for administering drugs into the body. The use of ultrasound frequencies generated by an ultrasound device (sonophoresis) has been shown to improve the effectiveness of this method. Studies have demonstrated that low-frequency ultrasound is more efficient in facilitating drug movement by creating an aqueous path in the skin through cavitation. This process involves the creation of small bubbles in the skin's fluid, which then collapse, creating micro-jets that push the drug molecules into the skin.To achieve this, drugs are mixed with a specific coupler, such as a gel or a cream, which transmits ultrasonic waves to the skin. The ultrasonic waves disturb the skin layers, creating an aqueous path through which the drug can be injected. The energy values between 20 kHz and 16 MHz have been found to be effective in creating these passages through the skin.In addition to facilitating drug penetration, ultrasound also increases the local temperature of the skin area, creating a thermal effect that further promotes drug penetration. Researchers have successfully delivered a variety of drugs using this method, including mannitol and high molecular weight drugs such as insulin, regardless of their solubility, dissociation and ionization constants, and electrical properties, including hydrophilicity.Despite the promising results, the exact mechanism of drug penetration through this method is not yet completely understood, and problems with device availability, duration of exposure and treatment cycles for delivery, and undesirable side effects including burns persist. Therefore, further research is needed to optimize this method and make it more widely available for use in drug delivery.

Electroporation

Electroporation is a technique that utilizes high voltage electric pulses ranging from 5 to 500 V for short exposure times (~ms) to permeabilize the skin and improve drug delivery. This method involves the formation of small pores in the stratum corneum (SC) that allow for easier diffusion of drugs. To ensure safe and painless drug administration, the electric pulses are introduced using closely positioned electrodes. Electroporation has been shown to be a very safe and painless procedure for drug delivery, and has been used to successfully deliver low molecular weight (MW) drugs such as doxorubicin, mannitol, or calcein, as well as high MW ones such as antiangiogenic peptides, oligonucleotides, and the negatively charged anticoagulant heparin. However, like any technique, it does have its disadvantages. One of the main drawbacks is its limited delivery loads, meaning that it may not be suitable for administering large amounts of drugs. Additionally, the process can cause massive cellular perturbation, sometimes even resulting in cell death. It can also lead to heating-induced drug damage and denaturation of protein and other biomacromolecular therapeutics. Overall, electroporation is a promising technique for drug delivery due to its ability to enhance drug permeability through the skin. However, it is important to carefully consider its limitations and potential drawbacks before implementing it as a drug delivery method.

Photomechanical Waves

The use of photodynamic waves to transmit drugs through the skin is an emerging area of research. These waves are able to penetrate the skin's outer layer, the stratum corneum (SC), by creating a temporary channel. This allows the drug to pass through and reach the intended location in the skin. Photomechanical waves are produced by exposing the skin to low levels of radiation. This limited ablation is typically achieved with an exposure of approximately 5-7 J/cm2 to reach a depth of 50-400 ?m. The advantage of this technique is that it results in a longer increase and duration of skin permeability as compared to other direct ablation techniques. However, it is important to control the properties of the photodynamic waves to ensure that the product is delivered to the intended depth in the skin. A single laser pulse can also generate a wave that increases skin permeability within minutes, allowing macromolecules to diffuse into the skin. This technique has been shown to successfully deliver dextran macromolecules of 40 kDa weight and 20 nm latex particles using a single photodynamic laser pulse of a 23-ns duration. In summary, photodynamic waves represent a promising approach for transdermal drug delivery. By creating temporary channels in the skin, they allow drugs to reach their intended location without the need for invasive procedures. With further research and development, this technique has the potential to revolutionize drug delivery and improve patient outcomes.

Microneedle

The microneedle drug delivery system has emerged as a groundbreaking technology that has revolutionized the field of transdermal drug delivery. It involves the use of tiny, micron-sized needles that pierce the skin and deliver drugs directly into the bloodstream. Microneedle technology is an active area of research, and scientists are focused on optimizing the technology for effective insertion and geometric measurements required for efficient drug delivery.

Microneedles come in several types, including solid microneedles, coated microneedles, hollow microneedles, dissolving microneedles, and hydrogel-forming microneedles. Each type of microneedle is used depending on the type and purpose of drug administration. Solid microneedles make a physical path through which drugs can be absorbed, while coated microneedles facilitate delivery of drugs coated on the surfaces of the needles as they enter the skin. Hollow microneedles are designed to deliver the drug continuously via needle bores into the skin, while dissolving microneedles dissolve in the skin, and the drugs are released gradually from the microneedle matrix. Hydrogel-forming microneedles utilize a drug-containing reservoir integrated with blank microneedles upon application. The fabrication of microneedles has been widely investigated, with the objective of developing materials that are safe and effective for use in drug delivery. Microneedles can be made using various materials, such as metal, ceramic, polymers, and silicon. The prepared microneedles can be of several types, including solid microneedles, drug-coated microneedles, dissolving microneedles, naturally delivered melting needles, and microneedle patches combined with diverse patch types. This technology has shown promising results in enhancing transdermal absorption of various active compounds, including small and large molecules, and macromolecules. Solid microneedles have been used to deliver a wide variety of drugs, including bovine serum albumin, amantadine hydrochloride, levodopa, and ovalbumin. Similarly, coated microneedles have been investigated for enhancing the delivery of desmopressin, insulin, DNA, exendin-4, botulinum toxin-A, and peptide-A. Hollow microneedles have also been utilized for transdermal delivery of insulin, potassium chloride, and vaccine nanoparticles. Dissolving microneedles have been explored for delivery of vancomycin hydrochloride, vitamin B12, rilpivirine, dutasteride, bevacizumab, albendazole, insulin, and sumatriptan. Hydrogel-forming microneedles have been used effectively to enhance transdermal absorption of various drugs, including ibuprofen sodium, ovalbumin, donepezil, bevacizumab, metformin hydrochloride, and macromolecules, such as proteins. Microneedles has several advantages over other drug delivery methods. It can improve patient compliance by reducing the need for frequent dosing, reduce the risk of side effects, and enhance drug efficacy. Since the drugs are delivered directly to the bloodstream, it helps in avoiding pain during drug administration. Microneedles allow loading of a greater amount of drug into the associated drug-loaded reservoir than could be loaded into the microneedle arrays themselves, leading to increased drug concentrations delivered into the skin. Furthermore, the use of hydrogel-forming microneedles only requires a one-step application process, leading to ease of administration.microneedle technology is a promising drug delivery method that has shown significant potential for enhancing transdermal drug absorption. With the development of new fabrication techniques, patients can expect even greater benefits from this innovative drug delivery approach. By understanding the different types of microneedles and the materials used to manufacture them, healthcare providers can ensure that their patients receive the medicine they need safely and effectively, thereby improving patient outcomes and quality of life.

Thermal Ablation

Transdermal drug delivery systems have experienced a rapid evolution in recent years, with new techniques and technologies being developed to improve drug delivery efficacy, reduce side effects, and enhance patient compliance. One such technique is thermal ablation, which involves the application of localized heat to create microchannels in the skin for enhanced drug delivery. This technique provides precise control of drug delivery, with the degree of alteration of the stratum corneum structure being proportional to the locally elevated temperature. The microchannels created are small enough to avoid any discomfort for the patient, and this technique offers effective delivery of both small and high molecular weight compounds. Laser and radiofrequency methods are commonly used to induce thermal ablation.Chemical enhancers are another approach to improve transdermal drug delivery. These enhancers work by increasing drug penetration through the skin. They can be used alone or in combination with other penetration enhancers to create synergistic systems that can significantly enhance drug delivery. Such systems include eutectic mixtures and nanoparticle composite self-assembled vesicles, which work by increasing the solubility of the drug in the skin and/or by altering the skin's permeability.Recent research has focused on utilizing molecular simulation methodologies to better understand the skin lipid barrier, mechanisms regulating penetration of molecules across the skin, and transport of penetration enhancers. This has led to the development of advanced transdermal drug delivery systems like microemulsions and vesicles that can deliver drugs more effectively and with fewer side effects.Transdermal drug delivery systems have significant potential to improve patient compliance and reduce healthcare costs. With the development of novel techniques like thermal ablation and the use of chemical enhancers, patients can benefit from better drug delivery efficacy and reduced side effects. Further research and development in this field can lead to the creation of even more effective and targeted transdermal drug delivery systems, bringing about a new era of drug delivery that is safe, efficient, and convenient for patients.

Vesicles

Vesicles are colloidal particles made up of amphiphilic molecules arranged in a bilayer with water inside them. They are used for transdermal absorption of both water-soluble and fat-soluble drugs and can provide sustained release of stored drugs. Liposomes, transfersomes, and ethosomes are the most commonly used vesicle systems. Liposomes are soft, circular vesicles that can encapsulate both water-soluble and fat-soluble substances, but are limited to the surface of the skin. Transfersomes have the unique ability to penetrate skin pores and carry macromolecular drugs.Ethosomes and transfersomes are types of lipid-based systems used for delivering drugs through the skin. Ethosomes have better stability and last longer than transfersomes because they contain ethanol, which helps in drug penetration and retention. Transfersomes, meanwhile, are highly deformable and can penetrate the skin deeply, but they may not be as stable as ethosomes. These vesicle systems are an effective and versatile way to deliver drugs through the skin and are widely used in various fields such as dermatology, cosmetics, and transdermal drug delivery systems.

Polymeric Nanoparticles

Polymeric nanoparticles (NPs) are garnering considerable interest in drug delivery systems. These nanocarriers, falling within the 1 to 1000 nm size range, are typically made through polymerization and crosslinking, often employing biodegradable materials such as gelatin and polylactic acid (PLA). Polymeric NPs offer advantages like targeted and controlled drug release, altering drug dynamics in vivo to prolong drug residence time in the bloodstream, thus enhancing bioavailability while minimizing toxicity and side effects. They also excel in protecting unstable drugs from degradation and ensuring sustained drug release, overcoming limitations of lipid-based systems. Polymers like polylactic acid, PLGA, polycaprolactone, and natural polyesters like chitosan, gelatin, and alginate are widely used in forming polymeric NPs, which can take forms such as nanospheres, nanocapsules, and polymer micelles.Polymeric NPs boast high mechanical strength and nondeformability, but they face challenges in breakdown, leading to extended drug storage. Following storage, drug release occurs, with drugs diffusing into deeper skin layers. Thus, polymeric NPs promise targeted and controlled drug delivery, improved bioavailability, and reduced side effects, with their robust mechanical properties overcoming lipid-based system limitations.

Nanoemulsion

Nanoemulsions, characterized by low viscosity and thermodynamic stability, consist of small oil droplets dispersed in an aqueous phase, stabilized by surfactants. With droplet sizes ranging from 100 to 1000 nm, nanoemulsions offer excellent wettability, making them ideal for topical skincare products. They provide benefits like high solubilization capacity, physical stability, improved bioavailability, ease of preparation, energy efficiency, and long shelf life.Nanoemulsions exhibit quicker transdermal time and better absorption compared to conventional topical preparations. They can be oil-in-water, water-in-oil, or bicontinuous/multiphasic emulsions, with oil-in-water nanoemulsions finding increased use as drug delivery systems for lipophilic compounds. Overall, nanoemulsions represent a versatile ingredient with numerous benefits in skincare and pharmaceutical applications.

METHODS USED DEPENDING UPON TYPES AND PURPOSE OF DRUG TO BE DELIVERED:

In transdermal drug delivery systems (TDDS), it is crucial to evaluate the efficiency and effectiveness of drug delivery. The methods employed for this evaluation vary depending on the type and purpose of the drug being delivered. However, the three most commonly used techniques include the use of diffusion cells, tape stripping, and microscopic and spectroscopic examination. Each of these methods employs a unique analysis approach to determine the efficacy of drug delivery.

Diffusion Cell Method

The diffusion cell method represents the cornerstone of assessing Transdermal Drug Delivery Systems (TDDS), offering researchers a meticulous lens into how drugs traverse the skin barrier. Among the various setups, the Franz diffusion cell configuration reigns supreme, embodying a nuanced interplay between the skin, pharmaceutical compounds, and formulation intricacies.At its core, the Franz diffusion cell comprises three pivotal components meticulously designed to mimic real-world scenarios. Firstly, there's the chamber designated for drug application, akin to a stage where the pharmaceutical actives make their debut. Then, a selectively permeable membrane takes center stage, akin to the skin's barrier, allowing for the controlled diffusion of drugs. Finally, the acceptor media chamber serves as the audience, eagerly awaiting samples to dissect and analyze, mirroring how drugs interact with bodily fluids post-application.Within the realm of diffusion cells, two archetypes dominate: static and flow-through cells, each offering distinct advantages. Static cells, exemplified by the Franz setup, provide researchers with the flexibility to position the donor, membrane, and acceptor units vertically or horizontally, catering to experimental needs. It's worth noting that Franz cells can assume two forms – open or closed from the top – each influencing pressure dynamics and subsequently affecting penetration measurements. However, recent technological strides have ushered in automated diffusion cell systems, relegating manual setups to obsolescence. These automated marvels streamline experimentation, mitigating human errors while expediting data acquisition.By leveraging the diffusion cell method, researchers embark on a profound journey, unraveling the intricate dance between drugs and the skin's physiology. This method serves as a beacon, illuminating the path toward TDDS refinement by elucidating how formulation nuances sculpt drug delivery outcomes. In essence, the diffusion cell method emerges not just as a tool but as a guiding compass, steering researchers toward transformative advancements in transdermal drug delivery.

Tape Stripping

Tape stripping is a widely favored method in dermatological research, offering a gentle yet effective means of exploring how topically applied formulations interact with the skin's outer layer, known as the stratum corneum (SC). This technique involves delicately removing a portion of the SC using specialized adhesive tape, followed by a meticulous examination of the skin residues left on the tape surface. Typically, researchers conduct tape stripping after allowing sufficient time for the applied formulation to interact with the skin. Depending on the experimental setup, the formulation may either be rinsed away or left in place to maintain its original composition for subsequent analysis.Consistency is paramount in tape stripping experiments to ensure reliable results. Applying the adhesive tape with uniform pressure minimizes variations in skin removal and ensures accurate data interpretation. Moreover, the rate at which the tape is removed influences the amount of SC material extracted; slower removal rates enhance adherence and yield a more comprehensive sample.Once the samples are collected, various analytical methods can be employed for further analysis. High-performance liquid chromatography (HPLC) offers precise quantification of specific compounds, while spectroscopic techniques provide valuable qualitative insights. Among these techniques, attenuated total reflectance-Fourier transform infrared spectroscopy (ATR-FTIR) stands out as a powerful tool. ATR-FTIR spectroscopy illuminates molecular interactions by measuring changes in atomic vibrations and bonding angles induced by infrared radiation absorption or scattering. This method generates detailed spectra, allowing researchers to discern qualitative and quantitative information regarding the depth of penetration and composition of the extracted substances.While tape stripping combined with ATR-FTIR spectroscopy presents a robust approach for characterizing skin penetration, interpreting the results can be challenging. The overlap of characteristic peaks between the skin and the analyte compounds necessitates careful analysis to differentiate and attribute observed spectral features accurately.Thus, tape stripping serves as an invaluable technique for investigating the penetration of topical formulations into the skin's SC layer. By integrating various analytical methods, particularly ATR-FTIR spectroscopy, researchers gain comprehensive insights into formulation behavior and skin interactions. However, careful interpretation of results is essential to extract meaningful conclusions from tape stripping experiments.

Microscopic And Spectroscopic Methods

Microscopic and spectroscopic methods are widely employed in the field of dermatology to gain insights into the spatial distribution of drugs within different skin layers and to shed light on the mechanism of penetration. These techniques have proven to be valuable tools to evaluate the effect of physical and chemical enhancers on skin permeability and to examine the therapeutic effectiveness of different formulations. Confocal laser scanning microscopy (CLSM) and two-photon fluorescence microscopy (2-PFM) are the two most commonly used microscopy-based techniques in dermatology. CLSM is a non-invasive method that utilizes fluorescence microscopy to examine skin structure without destroying tissue samples. This technique has been widely adopted to visualize fluorescent model compounds in the skin and to diagnose common skin dysfunction and identify malignant lesions. CLSM can be used for both in vivo and in vitro conditions to probe the mechanism underlying the promotion of transdermal transport by nanoparticle formulations. Fluorescent markers such as fluorescein, Nile red, and 5-bromodeoxyuridine can be included in the encapsulated nanostructured formulations to examine their penetration profile across skin tissue or skin appendages .Two-photon microscopy, on the other hand, is a more advanced imaging technique that has become an important tool for imaging skin cells. This setup commonly uses a Ti-sapphire laser as the excitation source and works with an adjustable Ti-sapphire high-frequency pulsed laser that emits red and near-infrared rays in the wavelength range of 650-1100 nm. The most significant advantage of two-photon microscopy is that the total energy delivered to the specimen is much lower than that of other techniques. Additionally, the two-photon excitation phenomenon involves fluorescence excitation of the sample in very small focal volumes, thereby reducing the possibility of photobleaching and photodamage. Skin samples can be studied without cryofixation or sectioning, and deep tissue imaging is possible using infrared excitation for UV-absorbing fluorophores. Although two-photon microscopy has some limitations, including the need for relatively expensive lasers and complex cooling systems, and a lower lateral resolution than other technologies, these limitations are not significant in practice. Thus, microscopic and spectroscopic methods have proven to be valuable tools in dermatology, providing important information about the spatial distribution of drugs within different skin layers, shedding light on the mechanism of penetration, and examining the therapeutic effectiveness of different formulations. CLSM and two-photon microscopy are two commonly used techniques in this field, each with its advantages and limitations.

ADDITIONAL INNOVATIVE APPROACHES:

Transdermal drug delivery presents notable advantages, including bypassing first-pass metabolism and ease of self-administration. However, the dense cellular structure and hydrophobic nature of the stratum corneum (SC) present challenges for certain drugs in conventional transdermal delivery systems. Various factors influence drug absorption into the skin. Skin physiology, such as SC thickness and lipid content in different skin layers, affects absorption rates. Capillary density in specific areas and the presence of hair follicles and sweat ducts also impact drug absorption. Body temperature influences vasodilation and blood flow, affecting absorption rates. Occlusive systems can enhance drug permeation by over-hydrating the skin. For effective absorption, drugs must exhibit sufficient solubility in both water and oil, typically reflected in a log partition coefficient (Log P) between 1.0 and 3.0. Molecular size also plays a role, with optimal absorption observed for compounds under 600 Da. The degree of ionization and melting point of the drug further affect skin permeation.To address these challenges, researchers have developed various methods to enhance drug absorption through the skin. These methods are categorized based on their generation and enhancement strategy. The first generation involves formulations like sprays, gels, and creams applied directly to the skin, utilizing passive diffusion for absorption. However, this method has limitations, leading to the development of more advanced enhancement techniques. Barry and Morrow have classified enhancement approaches into five methods, as depicted in the figure. These methods encompass a range of strategies to optimize transdermal drug delivery, offering potential solutions to overcome barriers and improve drug absorption

Drug Vehicle Interaction

Drug-vehicle interaction serves as a promising avenue for improving skin absorption, encompassing four distinct techniques: drug/prodrug selection, ion pairing, eutectic systems, and chemical potential or thermodynamic methods. Classified as second-generation transdermal drug delivery systems by Prausnitz and Langer, these strategies aim to enhance skin permeability without causing damage to deeper skin layers.One such technique is the prodrug approach, where an inactive moiety is linked to a drug through covalent interactions, rendering the modified drug more hydrophobic than the active form. This modification is crucial as the primary barrier of the stratum corneum consists of nonpolar lipids. Upon administration, the prodrug is metabolized into the active drug, thereby enhancing pharmacological activity. Examples of drugs investigated using this method include stavudine, naltrexone, and bupropion.Ion pairing, another method, is suitable for ionized drugs that are not readily absorbed through the stratum corneum. By adding the opposite ion species into the drug formulation, a neutral paired compound is formed, facilitating enhanced skin permeation. Upon application, the ion-paired molecules release the parent drug, which is then absorbed into the circulation. Drugs such as risedronate and bisoprolol have been successfully delivered using this method.Despite their advantages, drug-vehicle interaction methods have limitations. Prodrugs may lead to toxicity due to unpredictable metabolism and the potential production of toxic metabolites. Additionally, toxicity assessments of both the linking agent and the prodrug itself are imperative. The complex synthesis process and limited applicability to small molecules further constrain the prodrug approach. Furthermore, while ion-pairing and prodrug delivery methods offer enhancements, they still rely on passive diffusion techniques, highlighting the ongoing challenge posed by the stratum corneum in transdermal drug delivery.

Stratum Corneum Modifcation 

The stratum corneum (SC) is the outermost layer of the skin and acts as a barrier for transdermal drug delivery. Therefore, modifying the properties of the SC can lead to improved permeability of drugs into the skin. Two methods that have gained prominence in recent years for modifying the SC are skin hydration and the use of chemical enhancers.Skin hydration is a process that involves increasing the skin's water content and humidity, enabling the drug to more easily permeate into the SC. Several methods have been employed for maintaining water content, including the use of occlusive dressing and patches, preventing water loss by adding lipid excipients to the formulation, and increasing skin humidity using humectants. Research has shown that after hydration, the lipid bilayer of the SC separates, altering the permeability of the skin significantly. Furthermore, skin hydration using an occlusive system may reduce the diffusion resistance of the skin to xenobiotics and positively affect the flux of numerous drugs by increasing the amount permeated and ultimately affecting the absorption rate into the skin.Chemical enhancers, on the other hand, function by disrupting the lipid bilayer of the SC, interacting with proteins, or modifying the partition coefficient of the drug.The safety of transdermal enhancers is crucial, as they're widely utilized in various products to enhance drug permeation through the skin. However, not all chemicals are suitable for this purpose. They must meet several safety criteria: being inert, non-toxic, non-allergenic, non-irritating, ensuring rapid effects, aesthetically pleasing, and allowing quick recovery of skin barrier function post-use. Adhering to these standards ensures effective drug delivery without compromising skin health or safety. Different types of chemical enhancers have been identified and categorized based on their mechanism of action. Some of the commonly used enhancers include fatty acids, alcohols, surfactants, urea, and terpenes. Fatty acids interact and modify the lipid domains of the SC by disrupting lipid bilayer packing, resulting in increased drug permeation through the skin. Alcohols increase drug solubility in the SC by altering the solvent properties of the SC, resulting in an improvement in drug partitioning. Surfactants solubilize the lipids of the SC, disrupting the lipid and protein domains, and penetrate through the lipid bilayer. Urea disrupts SC lipids, increases the water content of the skin, and initiates keratolytic activity, thereby improving skin absorption of drugs. Terpenes, on the other hand, modify the solvent nature of the SC and improve drug partitioning into the SC, in addition to disrupting the SC lipid bilayers and modifying drug diffusivity.While chemical enhancers show promise in enhancing the transdermal delivery of drugs, some of them can be toxic and cause skin irritation at high concentrations. Moreover, the effective concentration for each type of chemical enhancer varies for each drug. Therefore, a combination approach, using different types of chemical enhancers, has been employed to investigate the different ways of increasing drug permeation across the skin. This combination has been categorized as the third generation of transdermal enhancement methods. Thus, the modification of the SC is a promising approach to improve the permeability of drugs into the skin. Skin hydration and the use of chemical enhancers are two methods that can be employed for modifying the SC. While chemical enhancers show significant promise, their safety and efficacy must be carefully evaluated before being used in pharmaceutical products to ensure that they are inert, nontoxic, nonallergenic, nonirritant, and do not cause any damage to the skin barrier function.

CONCLUSION:

In conclusion, the exploration of advancements and innovative approaches in transdermal drug delivery systems (TDDS) illuminates a promising frontier in pharmaceutical research and development. Beginning with an in-depth understanding of the intricate anatomy and physiology of the skin, coupled with insights into drug penetration mechanisms, researchers have laid a solid foundation for optimizing drug delivery through this route. The analysis of the advantages and disadvantages of TDDS underscores its potential to revolutionize drug administration, offering benefits such as improved patient compliance, sustained release, and reduced systemic side effects. However, challenges such as limited drug permeability and skin irritation necessitate ongoing innovation and refinement in TDDS design.A comprehensive review of the various types of TDDS reveals a diverse array of delivery systems tailored to specific therapeutic needs, ranging from passive diffusion-based methods to actively assisted approaches. Of particular significance are the electrically driven or assisted methods, including iontophoresis, sonophoresis, electroporation, photomechanical waves, microneedle technologies, thermal ablation, vesicles, polymeric nanoparticles, and nanoemulsion-based systems. These cutting-edge techniques harness the power of electrical, mechanical, and thermal stimuli to enhance drug permeation through the skin barrier, thereby optimizing therapeutic efficacy.Furthermore, methodological advancements such as diffusion cell techniques, tape stripping, and microscopic and spectroscopic methods play a pivotal role in evaluating drug-vehicle interactions and modulating the stratum corneum for enhanced permeability. These techniques provide crucial insights into the dynamics of drug delivery, facilitating the design of more efficient and targeted delivery systems.In light of the advancements discussed, it is evident that transdermal drug delivery holds immense potential for revolutionizing healthcare by offering non-invasive, convenient, and patient-friendly alternatives to traditional routes of drug administration. However, continued research efforts are essential to address remaining challenges and harness the full potential of TDDS in improving patient outcomes and advancing therapeutic interventions.

REFERENCES

1. Delly Ramadon1,2 · Maeliosa T. C. McCrudden3  · Aaron J. Courtenay4  · Ryan F. Donnelly. Enhancement strategies for transdermal drug delivery systems: current trends and applications . Drug Delivery and Translational Research (2022) 12:758–791 .https://doi.org/10.1007/s13346-021-00909-6
2. Woo Yeup Jeong† , Mina Kwon† , Hye Eun Choi† and Ki Su Kim. Recent advances in transdermal drug delivery systems: a review. Jeong et al. Biomaterials Research (2021) 25:24. https://doi.org/10.1186/s40824-021-00226-6
3. RESHMI JAYAPRAKASH, JAHNARA HAMEED, ANUPRIYA. AN OVERVIEW OF TRANSDERMAL DELIVERY SYSTEM. Vol 10, Issue 10, 2017. DOI: http://dx.doi.org/10.22159/ajpcr.2017.v10i10.19909
4. Nikhil S, Geta A, Rana AC, Zulfiqar A, Dinesh K. Areview: Transdermal drug delivery system: A Tool for novel drug delivery system. Int J Drug Dev Res 2011;3(3):70-84.
5. Tortora GJ, Bryan D. Principles of Anatomy and Physiology. 13th ed., Vol. 1. New York: J. Wiley; 2011. p. 154-61.
6. Vyas SP, Khar RK. Controlled Drug Delivery: Concepts and Advance. 1st ed. New Delhi: Vallabh Prakashan; 2002. p. 411-77.
7. Heather AE. Transdermal drug delivery: Penetration enhancement techniques. Curr Drug Deliv 2005;2(1):23-33.
8. Birger B, Bente S, Carsten UN. Passive Diffusion of Drug Substance: The Concepts of Flux and Permeability. Available from: http://www. pharmpress.com/files/docs/molbiopharmaceutics.sample.pdf.
9. Subrahmanyam CV. Text book of Physical Pharmaceutics. New Delhi: Vallabh Prakashan; 2010. p. 110-26.
10. Rakesh R, Anoop KR. Formulation and optimization of nano-sized ethosomes for enhanced transdermal delivery of cromolyn sodium. J Pharm Bioallied Sci 2012;4(4):333-40.
11. Williams AC, Barry BW. Penetration enhancers. Adv Drug Deliv Rev 2004;56(5):603-18.
12. Murali S, Nair SC, Priya A. Drug delivery research: Current status and future prospects. Int J Pharm Sci Rev Res 2016;40(1):94-9.
13. Tsai JC, Guy RH, Thornfeldt CR, Gao WN, Feingold KR, Elias PM. Metabolic approaches to enhance transdermal drug delivery 1. Effect of lipid synthesis inhibitors. J Pharm Sci 1996;85(6):643-8.
14. Arora A, Prausnitz MR, Mitragotri S. Micro-scale devices for transdermal drug delivery. Int J Pharm 2008;364(2):227-36.
15. Banga AK. Transdermal and Intradermal Delivery of Therapeutic Agents: Application of Physical Technology. Boca Raton, FL: RC Press; 2011.
16. Barry B. Transdermal drug delivery. In: Aulton EM, editor. Pharmaceutics: The Science of Dosage form Design. 2nd ed. New York: Harcourt Publishers; 2002. p. 499.
17. Wokovich AM, Prodduturi S, Doub WH, Hussain AS, Buhse LF. Transdermal drug delivery system (TDDS) adhesion as a critical safety, efficacy and quality attribute. Eur J Pharm Biopharm 2006;64(1):1-8.
18. Benson HA, Grice JE, Mohammed Y, Namjoshi S, Roberts MS. Topical and transdermal drug delivery: from simple potions to smart technologies. Curr Drug Deliv. 2019;16(5):444–60. https://doi.org/10.2174/15672018166661902 01143457.
19. Wang Y, Zeng L, Song W, Liu J. Influencing factors and drug application of iontophoresis in transdermal drug delivery: an overview of recent progress. Drug Deliv Transl Res. 2021. https://doi.org/10.1007/ s13346-021-00898-6
20. . Moarefian M, Davalos RV, Tafti DK, Acheniec LE, Jones CN. Modeling iontophoretic drug delivery in a microfluidic device. Lab Chip. 2020;20(18): 3310–21. https://doi.org/10.1039/D0LC00602E.
21. Byrne JD, Yeh JJ, DeSimone JM. Use of iontophoresis for the treatment of cancer. J Control Release. 2018;284:144–51. https://doi.org/10.1016/j.jconrel.2 018.06.020
22. Park J, Lee H, Lim GS, Kim N, Kim D, Kim YC. Enhanced transdermal drug delivery by sonophoresis and simultaneous application of sonophoresis and iontophoresis. AAPS PharmSciTech. 2019;20(3):96. https://doi.org/10.1208/ s12249-019-1309-z.
23. Seah BC, Teo BM. Recent advances in ultrasound-based transdermal drug delivery. Int J Nanomedicine. 2018;13:7749–63. https://doi.org/10.2147/IJN.S1 74759.
24. Charoo NA, Rahman Z, Repka MA, Murthy SN. Electroporation: An avenue for transdermal drug delivery. Curr Drug Deliv. 2010;7(2):125–36. https://doi. org/10.2174/156720110791011765.
25. Chen X, Zhu L, Li R, Pang L, Zhu S, Ma J, et al. Electroporation-enhanced transdermal drug delivery: effects of logP, pKa, solubility and penetration time. Eur J Pharm Sci. 2020;151:105410. https://doi.org/10.1016/j.ejps.2020.1 05410.
26. Dermol-?erne J, Pirc E, Miklav?i? D. Mechanistic view of skin electroporation – models and dosimetry for successful applications: an expert review. Expert Opin Drug Deliv. 2020;17(5):689–704. https://doi.org/10.1080/17425247.202 0.1745772.
27. Lin CH, Aljuffali IA, Fang JY. Lasers as an approach for promoting drug delivery via skin. Expert Opin Drug Deliv. 2014;11(4):599–614. https://doi. org/10.1517/17425247.2014.885501
28. Agrawal S, Gandhi SN, Gurgar P, Saraswathy N. Microneedles: An advancement to transdermal drug delivery system approach. J Appl Pharm Sci. 2020;10(3):149–59.
29. Zhao Z, Chen Y, Shi Y. Microneedles: a potential strategy in transdermal delivery and application in the management of psoriasis. RSC Adv. 2020; 10(24):14040–9. https://doi.org/10.1039/D0RA00735H.
30. Jung JH, Jin SG. Microneedle for transdermal drug delivery: current trends and fabrication. J Pharm Investig. 2021. https://doi.org/10.1007/s40005-021- 00512-4.
31. Shakya AK, Ingrole RSJ, Joshi G, Uddin MJ, Anvari S, Davis CM, et al. Microneedles coated with peanut allergen enable desensitization of peanut sensitized mice. J Control Release. 2019;314:38–47. https://doi.org/10.1016/j. jconrel.2019.09.022.
32. Lim J, Tahk D, Yu J, Min DH, Jeon NL. Design rules for a tunable merged-tip microneedle. Microsyst Nanoeng. 2018;4(1):1–10.
33. Dardano P, Caliò A, Palma VD, Bevilacqua MF, Matteo AD, Stefano LD. A photolithographic approach to polymeric microneedles array fabrication. Materials. 2015;8(12):8661–73. https://doi.org/10.3390/ma8125484.
34. Han D, Morde RS, Mariani S, Mattina AAL, Vignali E, Yang C, et al. 4D printing of a bioinspired microneedle array with backward-facing barbs for enhanced tissue adhesion. Adv Funct Mater. 2020;30(11):1909197. https:// doi.org/10.1002/adfm.201909197.
35. Xiao Z, Li X, Zhang P, Wang Y. Research of polymeric microneedles for transdermal drug delivery. Progress Chem. 2017;29(12):1518.
36. Balmert SC, Carey CD, Falo GD, Sethi SK, Erdos G, Korkmaz E, et al. Dissolving undercut microneedle arrays for multicomponent cutaneous vaccination. J Control Release. 2020;317:336–46. https://doi.org/10.1016/j. jconrel.2019.11.023.
37. Kim HM, Lim YY, An JH, Kim MN, Kim BJ. Transdermal drug delivery using disk microneedle rollers in a hairless rat model. Int J Dermatol. 2012;51(7): 859–63. https://doi.org/10.1111/j.1365-4632.2011.05343.x.
38. Li K, Yoo KH, Byun HJ, Lim YY, Kim MN, Hong HK, et al. The microneedle roller is an effective device for enhancing transdermal drug delivery. Int J Dermatol. 2012;51(9):1137–9. https://doi.org/10.1111/ j.1365-4632.2010.04703.x.
39. Bariya SH, Gohel MC, Mehta TA, Sharma OP. Microneedles: an emerging transdermal drug delivery system. J Pharm Pharmacol. 2012;64(1):11–29.
40. Lee YS, Kang TG, Cho HR, Lee GJ, Park OK, Kim SY, et al. Localized delivery of Theranostic nanoparticles and high-energy photons using microneedleson-bioelectronics. Adv Mater. 2021;33(24):2100425. https://doi.org/10.1002/a dma.202100425.
41. Du H, Liu P, Zhu J, Li Y, Zhang L, Zzhu J, et al. Hyaluronic acid-based dissolving microneedle patch loaded with methotrexate for improved treatment of psoriasis. ACS Appl Mater Interfaces. 2019;11(46):43588–98. https://doi.org/10.1021/acsami.9b15668
42. Alkilani AZ, Mccrudden MTC, Donnelly RF. Transdermal drug delivery: innovative pharmaceutical developments based on disruption of the barrier properties of the stratum corneum. Pharmaceutics. 2015;7(4):438–70. https:// doi.org/10.3390/pharmaceutics7040438.
43. Amjadi M, Mostaghaci B, Sitti M. Recent advances in skin penetration enhancers for transdermal gene and drug delivery. Curr Gene Ther. 2017; 17(2):139–46. Jeong et al. Biomaterials Research (2021) 25:24 Page 14 of 15
44. Li Y, Guo L, Lu W. Laser ablation-enhanced transdermal drug delivery. Photonics Lasers Med. 2013;2(4):315–22.
45. Szunerits S, Boukherroub R. Heat: a highly efficient skin enhancer for transdermal drug delivery. Front Bioeng Biotechnol. 2018;6:15. https://doi. org/10.3389/fbioe.2018.00015.
46. Parhi R, Mandru A. Enhancement of skin permeability with thermal ablation techniques: concept to commercial products. Drug Delivery Translat Res. 2021;11:817-41
47. Babaie S, Del Bakhshayesh AR, Ha JW, Hamishehkar H. Invasome: A novel nanocarrier for transdermal drug delivery. Nanomaterials. 2020;10(2):341. https://doi.org/10.3390/nano10020341.
48. Palac Z, Engesland A, Flaten GE, Škalko-Basnet N, Filipovi?-Gr?i? J, Vani? Ž. Liposomes for (trans)dermal drug delivery: the skin-PVPA as a novel in vitro stratum corneum model in formulation development. J Liposome Res. 2014; 24(4):313–22. https://doi.org/10.3109/08982104.2014.899368.
49. Rajan R, Jose S, Mukund VP, Vasudevan DT. Transferosomes-a vesicular transdermal delivery system for enhanced drug permeation. J Adv Pharm Technol Res. 2011;2(3):138–43. https://doi.org/10.4103/2231-4040.85524.
50. Zhang Z, Liu Y, Chen Y, Li L, Lan P, He D, et al. Transdermal delivery of 5- aminolevulinic acid by nanoethosome gels for photodynamic therapy of hypertrophic scars. ACS Appl Mater Interfaces. 2019;11(4):3704–14. https:// doi.org/10.1021/acsami.8b17498
51. Dhal S, Gavara RR, Pal K, Banerjee I, Mishra M, Giri S. Facile transdermal delivery of upconversion nanoparticle by iontophoresis-responsive magneto-upconversion oleogel. Nano Express. 2020;1(1):010012. https://doi. org/10.1088/2632-959X/ab81e1.
52. Jeong WY, Kim SD, Lee SY, Lee HS, Han DW, Yang SY, et al. Transdermal delivery of Minoxidil using HA-PLGA nanoparticles for the treatment in alopecia. Biomater Res. 2019;23(1):16. https://doi.org/10.1186/s40824-019-01 64-z.
53. Lee SY, Kang MS, Jeong WY, Han DW, Kim KS. Hyaluronic acid-based theranostic nanomedicines for targeted cancer therapy. Cancers. 2020;12(4): 940. https://doi.org/10.3390/cancers12040940.
54. Jijie R, Barras A, Boukherroub R, Szunerits S. Nanomaterials for transdermal drug delivery: beyond the state of the art of liposomal structures. J Mater Chem B. 2017;5(44):8653–75. https://doi.org/10.1039/C7TB02529G.
55. Escobar-Chávez JJ, Díaz-Torres R, Rodríguez-Cruz IM, Domínguez-Delgado CL, Morales RS, Ángeles-Anguiano E, et al. Nanocarriers for transdermal drug delivery. Res Rep Transdermal Drug Delivery. 2012;1:3–17.
56. . Buhecha MD, Lansley AB, Somavarapu S, Pannala AS. Development and characterization of PLA nanoparticles for pulmonary drug delivery: coencapsulation of theophylline and budesonide, a hydrophilic and lipophilic drug. J Drug Deliv Sci Technol. 2019;53:101128. https://doi.org/10.1016/j. jddst.2019.101128.
57. Szunerits S, Boukherroub R. Heat: a highly efficient skin enhancer for transdermal drug delivery. Front Bioeng Biotechnol. 2018;6:15. https://doi. org/10.3389/fbioe.2018.00015.
58. Ali A, Ahmad U. Nanoemulsion as a vehicle in transdermal drug delivery. Insights Biomed. 2018;3:15.
59. Raza R, Mittai A, Kumar P, Alam S, Prakash S, Chauhan N. Approaches and evaluation of transdermal drug delivery system. Int J Drug Dev Res. 2015; 7(1):222–33.
60. Sheth NS, Mistry RB. Formulation and evaluation of transdermal patches and to study permeation enhancement effect of eugenol. J. Appl. Pharm. Sci. 2011;1(3):96–101.
61. Lee JD, Kim JY, Jang HJ, Lee BM, Kim KB. Percutaneous permeability of 1- phenoxy-2-propanol, a preservative in cosmetics. Regul Toxicol Pharmacol. 2019;103:56–62. https://doi.org/10.1016/j.yrtph.2019.01.002.
62. Rajithaa P, Shammika P, Aiswarya S, Gopikrishnan A, Jayakumar R, Sabitha M. Chaulmoogra oil based methotrexate loaded topical nanoemulsion for the treatment of psoriasis. J Drug Deliv Sci Technol. 2019;49:463–76. https://doi. org/10.1016/j.jddst.2018.12.020.
63. Ramadon D, McCrudden MT, Courtenay AJ, Donnelly RF. Enhancement strategies for transdermal drug delivery systems: current trends and applications. Drug Deliv Transl Res. 2021;20:1–34.
64. Salamanca CH, Barrera-Ocampo A, Lasso JC, Camacho N, Yarce CJ. Franz diffusion cell approach for pre-formulation characterisation of ketoprofen semi-solid dosage forms. Pharmaceutics. 2018;10(3):148. https://doi.org/1 0.3390/pharmaceutics10030148.
65. Escobar-Chávez JJ, Merino-Sanjuán V, López-Cervantes M, Urban-Morlan Z, Piñón-Segundo E, Quintanar-Guerrero D, et al. The tape-stripping technique as a method for drug quantification in skin. J Pharm Pharm Sci. 2008;11(1): 104–30. https://doi.org/10.18433/J3201Z.
66. Russell LM, Guy RH. Novel imaging method to quantify stratum corneum in dermatopharmacokinetic studies: proof-of-concept with acyclovir formulations. Pharm Res. 2012;29(12):3362–72. https://doi.org/10.1007/s11 095-012-0831-4.
67. Gu Y, Yang M, Tang X. Lipid nanoparticles loading triptolide for transdermal delivery: mechanisms of penetration enhancement and transport properties. J Nanobiotechnol. 2018;16(1):1–14.
68. Ahn J, Kim KH, Choe K, Lim JH, Lee SK, Kim YS, et al. Quantitative twophoton microscopy imaging analysis of human skin to evaluate enhanced transdermal delivery by hybrid-type multi-lamellar nanostructure. Biomed Opt Express. 2018;9(8):3974–82. https://doi.org/10.1364/BOE.9.003974.
69. Berekméri A, Tiganescu A, Alase AA, Vital E, Stacey M, Wittmann M. Noninvasive approaches for the diagnosis of autoimmune/autoinflammatory skin diseases-a focus on psoriasis and lupus erythematosus. Front Immunol. 2019;10:1931. https://doi.org/10.3389/fimmu.2019.01931.
70. Ashtikar M, Matthäus C, Schmitt M, Krafft C, Fahr A, Popp J. Non-invasive depth profile imaging of the stratum corneum using confocal raman microscopy: first insights into the method. Eur J Pharm Sci. 2013;50(5):601– 8. https://doi.org/10.1016/j.ejps.2013.05.030.
71. Zhang LW, Monteiro-Riviere NA. Use of confocal microscopy for nanoparticle drug delivery through skin. J Biomed Opt. 2012;18(6):061214. https://doi.org/10.1117/1.JBO.18.6.061214.
72. Singh I, Morris A. Performance of transdermal therapeutic systems: effects of biological factors. Int J Pharm Investig. 2011;1:4–9.
73. Gazerani P, Arendt-Nielsen L. Cutaneous vasomotor reactions in response to controlled heat applied on various body regions of healthy humans: evaluation of time course and application parameters. Int J Physiol Pathophysiol Pharmacol. 2011;3:202–9
74. Verma A, Jain A, Hurkat P, Jain SK. Transfollicular drug delivery: current perspectives. Res Reports Transdermal Drug Deliv. 2016;5:1–17
75. Hao J, Ghosh P, Li SK, Newman B, Kasting GB, Raney SG. Heat efects on drug delivery across human skin. Expert Opin Drug Deliv. 2016;13:755–68.
76. Jones K, Cocker J, Dodd LJ, Fraser I. Factors afecting the extent of dermal absorption of solvent vapours: a human volunteer study. Ann Occup Hyg. 2003;47:145–50.
77. Zhai H, Maibach HI. Efects of skin occlusion on percutaneous absorption: an overview. Skin Pharmacol Appl Skin Physiol. 2001;14:1–10.
78. N’Da DD. Prodrug strategies for enhancing the percutaneous absorption of drugs. Molecules. 2014;19:20780–807
79. Chandrashekar N, Shobha RR. Physicochemical and pharmacokinetic parameters in drug selection and loading for transdermal drug delivery. Indian J Pharm Sci. 2008;70:94–6.
80. Barry BW. Novel mechanisms and devices to enable successful transdermal drug delivery. Eur J Pharm Sci. 2001;14:101–14.
81. Stott PW, Williams AC, Barry BW. Transdermal delivery from eutectic systems: enhanced permeation of a model drug, ibuprofen. J Control Release. 1998;50:297–308.
82. Morrow DIJ, McCarron PA, Woolfson AD, Donnelly RF. Innovative strategies for enhancing topical and transdermal drug delivery. Open Drug Deliv J. 2007;1:36–59
83. Marwah H, Garg T, Goyal AK, Rath G. Permeation enhancer strategies in transdermal drug delivery. Drug Deliv. 2016;23:564–78.
84. Yerramreddy TR, Milewski M, Penthala NR, Stinchcomb AL, Crooks PA. Novel 3-O-pegylated carboxylate and 3-O-pegylated carbamate prodrugs of naltrexone for microneedleenhanced transdermal delivery. Bioorganic Med Chem Lett. 2010;20:3280–3.
85. Morris AP, Brain KR, Heard CM. Skin permeation and ex vivo skin metabolism of O-acyl haloperidol ester prodrugs. Int J Pharm. 2009;367:44–50.
86. Nam SH, Xu YJ, Nam H, Jin GW, Jeong Y, An S, Park JS. Ion pairs of risedronate for transdermal delivery and enhanced permeation rate on hairless mouse skin. Int J Pharm. 2011;419:114–20.
87. Zhao H, Liu C, Quan P, Wan X, Shen M, Fang L. Mechanism study on ion-pair complexes controlling skin permeability: efect of ion-pair dissociation in the viable epidermis on transdermal permeation of bisoprolol. Int J Pharm. 2017;532:29–36.
88. Wang W, Song T, Wan X, Liu C, Zhao H, Fang L. Investigate the control release effect of ion-pair in the development of escitalopram transdermal patch using FT-IR spectroscopy, molecular modeling and thermal analysis. Int J Pharm. 2017;529:391–400.
89. Torky AS, Freag MS, Nasra MMA, Abdallah OY. Novel skin penetrating berberine oleate complex capitalizing on hydrophobic ion pairing approach. Int J Pharm. 2018;549:76–86.
90. Cui H, Quan P, Zhao H, Wen X, Song W, Xiao Y, Zhao Y, Fang L. Mechanism of ion-pair strategy in modulating skin permeability of zaltoprofen: Insight from molecular-level resolution based on molecular modeling and confocal laser scanning microscopy. J Pharm Sci. 2015;104:3395–403.
91. Li Q, Wan X, Liu C, Fang L. Investigating the role of ionpair strategy in regulating nicotine release from patch: mechanistic insights based on intermolecular interaction and mobility of pressure sensitive adhesive. Eur J Pharm Sci. 2018;119:102–11.
92. Karpagavalli L, Vigneshwar M, Monisha M, Prabavathi M, Prasanth P, Zairudeen K. A review on prodrugs. Int J Nov Trends Pharm Sci. 2016;6:1–5.
93. Najjar A, Najjar A, Karaman R. Newly developed prodrugs and prodrugs in development; an insight of the recent years. Molecules. 2020;5:1–18.
94. Grimaldi N, Andrade F, Segovia N, Ferrer-Tasies L, Sala S, Veciana J, Ventosa N. Lipid-based nanovesicles for nanomedicine. Chem Soc Rev. 2016;45:6520–45.
95. Bangham AD, Horne RW. Negative staining of phospholipids and their structural modifcation by surface-active agents as observed in the electron microscope. J Mol Biol. 1964;8:660–8.
96. Akbarzadeh A, Rezaei-Sadabady R, Davaran S, Joo SW, Zarghami N, Hanifehpour Y, Samiei M, Kouhi M, Nejati-Koshki K. Liposome: classification, preparation, and applications. Nanoscale Res Lett. 2013;8:1–9.
97. Li J, Wang X, Zhang T, Wang C, Huang Z, Luo X, Deng Y. A review on phospholipids and their main applications in drug delivery systems. Asian J Pharm Sci. 2015;10:81–98.
98. Bozzuto G, Molinari A. Liposomes as nanomedical devices. Int J Nanomedicine. 2015;10:975–99.
99. Safnya CR, Ewert KK. Liposomes derived from molecular vases. Nature. 2012;489:372–4.
100. Sacha M, Faucon L, Hamon E, Ly I, Haltner-Ukomadu E. Ex vivo transdermal absorption of a liposome formulation of diclofenac. Biomed Pharmacother. 2019;111:785–90.
101. Kim AR, Lee NH, Park YM, Park SN. Preparation and characterization of novel pseudo ceramide liposomes for the transdermal delivery of baicalein. J Drug Deliv Sci Technol. 2019;52:150–6.
102. Manosroi A, Kongkaneramit L, Manosroi J. Stability and transdermal absorption of topical amphotericin B liposome formulations. Int J Pharm. 2004;270:279–86.
103. Maestrelli F, González-Rodríguez ML, Rabasco AM, Mura P. Efect of preparation technique on the properties of liposomes encapsulating ketoprofen-cyclodextrin complexes aimed for transdermal delivery. Int J Pharm. 2006;312:53–60.
104. Zhou W, Liu W, Zou L, Liu W, Liu C, Liang R, Chen J. Storage stability and skin permeation of vitamin C liposomes improved by pectin coating. Colloids Surf B Biointerfaces. 2014;117:330–7.
105. Peralta MF, Guzmán ML, Pérez AP, Apezteguia GA, Fórmica ML, Romero EL, Olivera ME, Carrer DC. Liposomes can both enhance or reduce drugs penetration through the skin. Sci Rep. 2018;8:1–11.
106. Tan G, Xu P, Lawson LB, He J, Freytag LC, CLements JD, John VT. Hydration efects on skin microstructure as probed by high-resolution cryo-scanning electron microscopy and mechanistic implications to enhanced transcutaneous delivery of biomacromolecules. J Pharm Sci. 2010;99:730–40.
107. Paudel KS, Milewski M, Swadley CL, Brogden NK, Ghosh P, Stinchcomb AL. Challenges and opportunities in dermal/ transdermal delivery. Ther Deliv. 2010;1:109–31. 786 Drug Delivery and Translational Research (2022) 12:758–791 1 3
108. Karande P, Mitragotri S. Enhancement of transdermal drug delivery via synergistic action of chemicals. Biochim Biophys Acta - Biomembr. 2009;1788:2362–73.
109. Singh S, Singh J. Transdermal drug delivery by passive difusion and iontophoresis: a review. Med Res Rev. 1993;13:569–621.
110. Williams AC, Barry BW. Penetration enhancers. Adv Drug Deliv Rev. 2012;64:128–37.
111. Mueller J, Trapp M, Neubert RHH. The efect of hydrophilic penetration/difusion enhancer on stratum corneum lipid models: Part II*: DMSO*. Chem Phys Lipids. 2019;225:1–8.
112. Elshafeey AH, Hamza YE, Amin SY, Zia H. In  vitro transdermal permeation of fenoterol hydrobromide. J Adv Res. 2012;3:125–32.
113. Maibach HI, Feldmann R. The efect of DMSO on percutaneous penetration of hydrocortisone and testosterone in man. Ann N Y Acad Sci. 1967;141:423–7.
114. Hadgraft J, Lane M. Transdermal delivery of testosterone. Eur J Pharm Biopharm. 2015;92:42–8.
115. Jaiswal J, Poduri R, Panchagnula R. Transdermal delivery of naloxone: ex  vivo permeation studies. Int J Pharm. 1999;179:129–34.
116. Chen HL, Cai CC, Ma JY, Yu ML, Zhao MH, Guo JB, Xu H. Efect of the dispersion states of azone in hydroalcoholic gels on its transdermal permeation enhancement efcacy. J Pharm Sci. 2018;107:1879–85.
117. Liu C, Guan Y, Tian Q, Shi X, Fang L. Transdermal enhancement strategy of ketoprofen and terifunomide: the efect of enhanced drug-drug intermolecular interaction by permeation enhancer on drug release of compound transdermal patch. Int J Pharm. 2019;572:1–10.
118. Ameen D, Michniak-Kohn B. Transdermal delivery of dimethyl fumarate for Alzheimer’s disease: efect of penetration enhancers. Int J Pharm. 2017;529:465–73.
119. Singh BN, Singh RB, Singh J. Effects of ionization and penetration enhancers on the transdermal delivery of 5-fuorouracil through excised human stratum corneum. Int J Pharm. 2005;298:98–107.
120. Lee PJ, Langer R, Shastri VP. Role of n-methyl pyrrolidone in the enhancement of aqueous phase transdermal transport. J Pharm Sci. 2005;94:912–7.
121. Ogiso T, Hata T, Iwaki M, Tanino T. Transdermal absorption of bupranolol in rabbit skin in vitro and in vivo. Biol Pharm Bull. 2001;24:588–91.
122. Liu W, Teng L, Yu K, Sun X, Fan C, Long C, Liu N, Li S, Wu B, Xu Q, Sun F, Li Y. Design of hydrogels of 5-hydroxymethyl tolterodine and their studies on pharmacokinetics, pharmacodynamics and transdermal mechanism. Eur J Pharm Sci. 2017;96:530–41.
123. Van ZL, Du PJ, Gerber M, Du PJ, Viljoen J. Essential fatty acids as transdermal penetration enhancers. J Pharm Sci. 2016;105:188–93.
124. Stott PW, Williams AC, Barry BW. Mechanistic study into the enhanced transdermal permeation of a model ?-blocker, propranolol, by fatty acids: a melting point depression efect. Int J Pharm. 2001;219:161–76.
125. Klimentová J, Kosák P, Vávrová K, Holas T, Hrabálek A. Infuence of terminal branching on the transdermal permeationenhancing activity in fatty alcohols and acids. Bioorganic Med Chem. 2006;14:7681–7.
126. Choi J, Choi MK, Chong S, Chung SJ, Shim CK, Kim DD. Efect of fatty acids on the transdermal delivery of donepezil: in vitro and in vivo evaluation. Int J Pharm. 2012;422:83–90.
127. Magnusson BM, Runn P, Karlsson K, Koskinen LOD. Terpenes and ethanol enhance the transdermal permeation of the tripeptide thyrotropin releasing hormone in human epidermis. Int J Pharm. 1997;157:113–21.
128. Melero A, Garrigues TM, Almudever P, Villodre AM, Lehr CM, Schäfer U. Nortriptyline hydrochloride skin absorption: development of a transdermal patch. Eur J Pharm Biopharm. 2008;69:588–96.
129. Haq A, Michniak-Kohn B. Efects of solvents and penetration enhancers on transdermal delivery of thymoquinone: permeability and skin deposition study. Drug Deliv. 2018;25:1943–9.
130. Stahl J, Kietzmann M. The efects of chemical and physical penetration enhancers on the percutaneous permeation of lidocaine through equine skin. BMC Vet Res. 2014;10:1–6.
131. Som I, Bhatia K, Yasir M. Status of surfactants as penetration enhancers in transdermal drug delivery. J Pharm Bioallied Sci. 2012;4:2–9.
132. Nokhodchi A, Shokri J, Dashbolaghi A, Hassan-zadeh D, Ghafourian T, Barzegar-Jalali M. The enhancement efect of surfactants on the penetration of lorazepam through rat skin. Int J Pharm. 2003;250:359–69.
133. Piret J, Desormeaux A, Cormier H, Lamontagne J, Gourde P, Juhasz J, Bergeron M. Sodium lauryl sulfate increases the efcacy of a topical formulation of foscarnet against herpes simplex virus type 1 cutaneous lesions in mice. Antimicrob Agents Chemother. 2000;44:2263–70.
134. Akhtar N, Rehman MU, Khan HMS, Rasool F, Saeed T, Murtaza G. Penetration enhancing efect of polysorbate 20 and 80 on the in vitro percutaneous absorption of L-ascorbic acid. Trop J Pharm Res. 2011;10:281–8.
135. Ogiso T, Iwaki M, Paku T. Efect of various enhancers on transdermal penetration of indomethacin and urea, and relationship between penetration parameters and enhancement factors. J Pharm Sci. 1995;84:482–8.
136. Vijaya C, Bingi M, Vigneshwaran LV. Transdermal delivery of venlafaxine hydrochloride: the effects of enhancers on permeation across pig ear skin. Indian J Pharm Sci. 2011;73:456–9.
137. Björklund S, Engblom J, Thuresson K, Sparr E. Glycerol and urea can be used to increase skin permeability in reduced hydration conditions. Eur J Pharm Sci. 2013;50:638–45.
138. Chen J, Jiang QD, Chai YP, Zhang H, Peng P, Yang XX. Natural terpenes as penetration enhancers for transdermal drug delivery. Molecules. 2016;21:1–22.
139. Amnuaikit C, Ikeuchi I, Ogawara KI, Higaki K, Kimura T. Skin permeation of propranolol from polymeric film containing terpene enhancers for transdermal use. Int J Pharm. 2005;289:167–78.
140. Serna-Jiménez CE, Del Rio-Sancho S, Calatayud-Pascual MA, Balaguer-Fernández C, Femenía-Font A, López-Castellano A, Merino V. Development of antimigraine transdermal delivery systems of pizotifen malate. Int J Pharm. 2015;492:223–32.
141. Narishetty STK, Panchagnula R. Transdermal delivery of zidovudine: efect of terpenes and their mechanism of action. J Control Release. 2004;95:367–79.
142. Jain AK, Thomas NS, Panchagnula R. Transdermal drug delivery of imipramine hydrochloride: I. Efect of terpenes J Control Release. 2002;79:93–101.
143. Bavaskar K, Jain A, Patil M, Kalamkar R, Bavaskar KR, Professor A. The impact of penetration enhancers on transdermal drug delivery system: physical and chemical approach. Int J Pharma Res Rev. 2015;4:14–24.
144. Gangarosa LP Sr, Hill JM. Modern iontophoresis for local drug delivery. Int J Pharm. 1995;123:159–71.
145. Kassan DG, Lynch AM, Stiller MJ. Physical enhancement of dermatologic drug delivery: iontophoresis and phonophoresis. J Am Acad Dermatol. 1996;34:657